Cryo Fusion Products Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 30-06-2024
- Paid Up Capital ₹ 2.28 M
as on 30-06-2024
- Company Age 37 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit 1197.43%
(FY 2021)
- Ebitda 74.17%
(FY 2021)
- Net Worth 12.64%
(FY 2021)
- Total Assets 1.75%
(FY 2021)
About Cryo Fusion Products
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.28 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Agrawal and Rina Agrawal serve as directors at the Company.
- CIN/LLPIN
U74899DL1987PTC028766
- Company No.
028766
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cryo Fusion Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Agrawal  | Director | 15-Nov-2021 | Current |
| Rina Agrawal | Director | 02-May-1994 | Current |
Financial Performance of Cryo Fusion Products.
Cryo Fusion Products Private Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1197.43% increase in profit. The company's net worth Soared by an impressive increase of 12.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cryo Fusion Products?
In 2021, Cryo Fusion Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Universal Industrial Plants Mfg.Co. Private LimitedActive 38 years 3 monthsAditya Agrawal and Rina Agrawal are mutual person
Surabhi Fabs Private LimitedActive 18 years 8 monthsAditya Agrawal and Rina Agrawal are mutual person
Delhi Cryogenic Products Private LimitedActive 37 years 5 monthsAditya Agrawal and Rina Agrawal are mutual person
Betterdeal Machineries Private LimitedActive 27 years 2 monthsAditya Agrawal and Rina Agrawal are mutual person
Universal Ing.La.Boschi Plants Private LimitedActive 5 years 5 monthsAditya Agrawal and Rina Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cryo Fusion Products?
Unlock and access historical data on people associated with Cryo Fusion Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cryo Fusion Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cryo Fusion Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
